home / stock / agtc / agtc news

AGTC News and Press, Applied Genetic Technologies Corporation From 08/07/19

Stock Information
Company Name: Applied Genetic Technologies Corporation
Stock Symbol: AGTC
Market: NASDAQ
Website: agtc.com
Menu
AGTC AGTC Quote AGTC Short AGTC News AGTC Articles AGTC Message Board
Get AGTC Alerts

News, Short Squeeze, Breakout and More Instantly...
AGTC - AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 14, 2019

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...
AGTC - Applied Genetic Technologies (AGTC) Investor Presentation - Slideshow

The following slide deck was published by Applied Genetic Technologies Corporation in conjunction with this Read more ...

AGTC - AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Study

GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 23, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

AGTC - AGTC to Present at BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference on June 25, 2019

GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...
AGTC - Applied Genetic Technologies Corporation (AGTC) CEO SueWasher on Q3 2019 Results - Earnings Call Transcript

Applied Genetic Technologies Corporation (AGTC) Q3 2019 Earnings Conference Call May 7, 2019 8:00 AM ET Company Participants Sue Washer – Chief Executive Officer Matt Feinsod – Chief Medical Officer Bill Sullivan – Chief Financial Officer Conference Call P...

AGTC - Applied Genetic beats by $1.16

Applied Genetic (NASDAQ: AGTC ): Q3 GAAP EPS of $0.63 beats by $1.16 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

AGTC - AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2019

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced...
AGTC - AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 7, 2019

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announc...

AGTC - AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials

GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announ...

AGTC - Applied Genetic Technologies- An Eye on Optogenetics

Applied Genetic Technologies ( AGTC ) is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases, explains Bill Mathews , small cap expert and editor of ...
Previous 10 Next 10